Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sofia Costa-De-Oliveira has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Active Screening for C. auris Colonisation: A Preventive Step or an Excessive Measure? A Systematic Review

    by Margarida Alves, Elisabete Ricardo, Sofia Costa de Oliveira

    Background: Patients’ and surfaces’ colonisation play a pivotal role in C. auris transmission. Understanding how, when, and where screening for colonisation should be done is important to control the spread. Methods: This systematic review searched studies regarding C. auris patient colonisation, without previous outbreaks, until October 2024. Patient demographic and clinical data, sample type, collecting procedure, laboratory methods for strain identification, Clade determination, and susceptibility profile were collected. Results: Thirty-eight studies published between 2019 and 2023 across 18 countries were included using well-established inclusion criteria. Various body sites were screened mainly in patients admitted to intensive care units (ICUs). Patients had various comorbidities and were more commonly colonised during hospitalisation, compared to admission. Most of the isolates belonged to Clade I. Of 19 studies determining antifungal susceptibility, 15 reported resistance, mainly to azoles. Azole resistance was consistently associated with ERG11 substitutions (Y132F/K143R in Clade I, and V125A/F126L in Clade III). Conclusions: Healthcare workers should be on high alert for older, long-term hospitalised, ICU patients with comorbidities and co-colonisation with other pathogens. Composite bilateral axilla-groin sampling should remain the standard minimum approach. Additional anatomical sites may be considered. Well-equipped laboratories are vital for precision identification and antifungal susceptibility testing.


  • Plesiozyma aurantiaca gen. et sp. nov. (Ustilaginaceae, Ustilaginales), a novel Ustilaginomycetes yeast from an urban lake in Portugal

    by Nuno Reisinho, Sofia Costa de Oliveira, Dolores Pinheiro, Artur Alves, Micael F.M. Gonçalves

    A novel yeast-like basidiomycete was recovered from an urban lake in a public park in the city of Aveiro, Portugal. Sequence comparisons based on LSU rRNA, SSU rRNA, internal transcribed spacer (ITS) region and tef1-α gene sequences, together with phylogenetic analysis using the widely available ITS and LSU markers, placed the isolate within the family Ustilaginaceae , where it forms a well-supported and distinct lineage within clade 7, clearly separated from the closely related genera Moesziomyces and Macalpinomyces . Clade 7 comprises species traditionally assigned to the genera Ustilago , Sporisorium and Macalpinomyces , a grouping that reflects the taxonomic complexity and instability of this lineage. Morphological, physiological, biochemical characteristics and antifungal susceptibility determination were performed to characterize the isolate. Colonies were orange and mucoid, with ovoid to elongated budding vegetative cells and occasional pseudohyphae. Optimal growth occurred at 30 °C, with tolerance up to 40 °C, indicating an unusual degree of thermotolerance among ustilaginaceous yeasts. Biochemical profiling revealed broad assimilation of simple sugars, organic acids and polyols, together with urease activity and nitrate assimilation, consistent with adaptation to dissolved organic matter in urban freshwater environments. Antifungal susceptibility testing showed low MICs for amphotericin B, whereas echinocandins exhibited reduced in vitro activity, consistent with patterns reported for other ustilaginaceous and basidiomycetous yeasts. Based on our findings, we propose a new genus, Plesiozyma gen. nov., and a new species, Plesiozyma aurantiaca sp. nov. (MUM 25.31 as type species, MycoBank number: MB862570), to accommodate this novel yeast-like fungus isolated from urban water.

  • Open Access

    Gut Microbiota Composition and Diversity in Attention-Deficit/Hyperactivity Disorder: A Systematic Review

    by Beatriz Rodrigues, Isabel M. Miranda, Sofia Costa de Oliveira

    Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition. Growing evidence suggests that the gut–brain axis may contribute to its pathophysiology. However, findings regarding gut microbiota alterations in ADHD remain inconsistent. This systematic review aimed to synthesize the current evidence on the gut microbiota composition and microbial diversity in individuals with ADHD. A systematic search of PubMed, Scopus, and Web of Science was conducted up to 31 December 2025 following PRISMA guidelines, yielding 562 studies. Twenty-three studies published between 2015 and 2025 were included. Most studies reported no significant differences in alpha-diversity in ADHD and control groups. More consistently, beta-diversity analysis reported significant differences in microbial composition between ADHD and control groups. ADHD was often associated with a reduced abundance of Alistipes and butyrate producers such as Faecalibacterium and increased abundance of Roseburia and Agathobacter. Some longitudinal studies suggested that distinct early-life microbial patterns may precede the ADHD diagnosis. ADHD appears to be associated with alterations in the gut microbiota, particularly in taxa involved in short-chain fatty acid production and immune regulation. However, findings remain inconsistent due to methodological heterogeneity and potential confounding factors. Future research should prioritize longitudinal multi-omics approaches to clarify causal mechanisms and refine microbiota-targeted interventions.


  • Open Access

    Here today, gone tomorrow: the transformative role of biodegradable materials in modern trauma care

    by Miguel Marta, Pedro Miguel Machado, Luís Oliveira, Isabel Marcos Miranda, M Fátima Vaz, Sofia Costa de Oliveira

    Purpose: Methods: Results: Conclusion:

  • Open Access

    First Report of Candida auris Candidemia in Portugal: Genomic Characterisation and Antifungal Resistance-Associated Genes Analysis

    by Isabel M. Miranda, Micael F. M. Gonçalves, Dolores Pinheiro, Sandra Hilário, José Artur Paiva, João Tiago Guimarães, Sofia Costa de Oliveira

    Candida auris has emerged as a global public health threat due to its high mortality rates, multidrug resistance, and rapid transmission in healthcare settings. This study reports the first documented cases of C. auris candidemia in Portugal, comprising eight isolates from candidemia and colonised patients admitted to a major hospital in northern Portugal in 2023. Whole-genome sequencing (WGS) was performed to determine the phylogenetic relationships of the isolates, which were classified as belonging to Clade I. Genome sequencing also enabled the detection of missense mutations in antifungal resistance genes, which were correlated with antifungal susceptibility profiles determined according to EUCAST (European Committee on Antimicrobial Susceptibility Test) protocols and guidelines. All isolates exhibited resistance to fluconazole and amphotericin B according to the recently established EUCAST epidemiological cut-offs (ECOFFs). Most of the isolates showed a resistant phenotype to anidulafungin and micafungin. All isolates were resistant to caspofungin. Missense mutations identified included Y132F in ERG11, E709D in CDR1, A583S in TAC1b, K52N and E1464K in SNQ2, K74E in CIS2, M192I in ERG4, a novel mutation S237T in CRZ1, and variants in GCN5, a gene involved in chromatin remodelling and stress-response regulation. Identifying known and novel mutations highlights the evolution of antifungal resistance mechanisms in C. auris. These findings underscore the need for further research to understand C. auris resistance pathways and to guide effective clinical management strategies.


  • Open Access

    Mechanical Characterization and Azithromycin Coating of Melt Electrowritten Polycaprolactone Mesh Implants for Prolapse Repair

    by Joana Pinheiro Martins, Ana Sofia Sousa, Sofia Costa de Oliveira, António Augusto Fernandes, Elisabete Silva

    Pelvic organ prolapse (POP) cases have been rising, affecting women’s quality of life. Severe cases often require surgical mesh implants, which can cause complications like tissue erosion and infection, leading the FDA to ban transvaginal meshes for POP. To address this, polycaprolactone (PCL) mesh implants, produced via melt electrowriting (MEW), were evaluated mechanically and coated with azithromycin, an antibiotic for genitourinary infections. Uniaxial tensile and cyclic tests assessed the long-term behavior of the meshes over 100 cycles. The results show that while all PCL meshes had similar behavior, those with 1 mm pores sustained higher stress, whereas 1.5 mm pore size meshes had mechanical properties closer to vaginal tissue but remained stiffer. Cyclic tests revealed initial damage and hardening during plastic deformation, with tensile tests confirming increased stiffness, as Young’s modulus rose between 19.2% and 29.3%. Zone inhibition and biofilm assays evaluated azithromycin’s effectiveness against bacterial infection. Even though FTIR analysis could not confirm antibiotic incorporation, the drug coated meshes show inhibitory activity against E. coli biofilm formation and MSSA in its planktonic state. Scanning Electron Microscopy supported these findings. These results suggest that MEW-fabricated PCL meshes coated with azithromycin hold promise as improved implants for POP treatment.


  • Open Access

    Antibiotic-Coated Melt Electrowritten Polycaprolactone Meshes: Fabrication and In Vitro Antibacterial Evaluation

    by Joana Pinheiro Martins, Ana Sofia de Sousa, Sofia Costa de Oliveira, António Augusto Fernandes, Elisabete Teixeira da Silva

    In recent years, pelvic organ prolapse (POP) cases have been rising, affecting women’s quality of life. Synthetic surgical transvaginal meshes used for POP treatment were withdrawn from the United States market in 2019 due to high risks, including infection, vaginal mesh erosion, and POP reoccurrence. Biodegradable mesh implants with three-dimensional printing technology have emerged as an innovative alternative. In this study, polycaprolactone (PCL) meshes for POP repair were fabricated using melt electrospinning writing (MEW) and mechanically evaluated through uniaxial tensile tests. Following this, they were coated with antibiotics—azithromycin, gentamicin sulfate, and ciprofloxacin—commonly used for genitourinary tract infections. Zone inhibition and biofilm assays evaluated antibiotic effectiveness in preventing mesh infections by Escherichia coli, and methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus. The meshes presented a mechanical behavior closer to vaginal tissue than commercially available meshes. Fourier transform infrared analysis confirmed antibiotic incorporation. Ciprofloxacin demonstrated antibacterial activity against MRSA, with a 92% reduction in metabolic activity and a 99% biomass reduction. Gentamicin and ciprofloxacin displayed inhibitory activity against MSSA and E. coli. Scanning electron microscopy images support these conclusions. This methodology may offer a more effective, patient-friendly solution for POP repair, improving healing and the quality of life for affected women.


  • Open Access

    Global Epidemiology of Invasive Infections by Uncommon Candida Species: A Systematic Review

    by Sandra Pinho, Isabel M. Miranda, Sofia Costa-De-Oliveira

    Emerging and uncommon Candida species have been reported as an increasing cause of invasive Candida infections (ICI). We aim to systematize the global epidemiology associated with emergent uncommon Candida species responsible for invasive infections in adult patients. A systematic review (from 1 January 2001 to 28 February 2023) regarding epidemiological, clinical, and microbiological data associated to invasive Candida infections by uncommon Candida spp. were collected. In total, 1567 publications were identified, and 36 were selected according to inclusion criteria (45 cases). The chosen studies covered: C. auris (n = 21), C. haemulonii (n = 6), C. fermentati (n = 4), C. kefyr (n = 4), C. norvegensis (n = 3), C. nivariensis (n = 3), C. bracarensis (n = 1), C. duobushaemulonii (n = 1), C. blankii (n = 1), and C. khanbhai (n = 1). Over the recent years, there has been an increase in the number of invasive infections caused by uncommon Candida spp. Asia and Europe are the continents with the most reported cases. The challenges in strain identification and antifungal susceptibility interpretation were significant. The absence of clinical breakpoints for the susceptibility profile determination for uncommon Candida spp. makes interpretation and treatment options a clinical challenge. It is crucial that we focus on new and accessible microbiology techniques to make fast and accurate diagnostics and treatments.


  • Open Access

    Development and Evaluation of Microencapsulated Oregano Essential Oil as an Alternative Treatment for Candida albicans Infections

    by Liliana Fernandes, Ainara Barco-Tejada, Elena Blázquez, Daniela Araújo, Artur Ribeiro, Sónia Silva, Lorena Cussó, Sofia Costa-De-Oliveira, M. Elisa Rodrigues, Mariana Henriques

    Vulvovaginal candidiasis (VVC) is characterized as a very common fungal infection that significantly affects women's health worldwide. Essential oils (EOs) are currently being evaluated as an alternative therapy. The development of efficient techniques such as micro- or nanoencapsulation for protecting and controlling release is essential to overcome the limitations of EO applications. Therefore, the aim of this study was to develop and characterize oregano EO-loaded keratin microparticles (OEO-KMPs) as a potential treatment for VVC. OEO-KMPs were produced using high-intensity ultrasonic cycles and characterized in terms of morphological and physicochemical parameters. In vitro evaluation included assessing the toxicity of the OEO-KMPs and their effect against Candida albicans using microdilution and agar diffusion, while the activity against biofilm was quantified using colony forming units (CFU). The efficacy of the OEO-KMPs in an in vivo VVC mouse model was also studied. Female BALB/c mice were intravaginally infected with C. albicans, 24 h postinfection animals were treated intravaginally with 15 μL of OEO-KMPs and 24 h later vaginal fluid was analyzed for C. albicans and Lactobacillus growth (CFU mL-1). The results showed the stability of the OEO-KMPs over time, with high encapsulation efficiency and controlled release. This nanoparticle size facilitated penetration and completely inhibited the planktonic growth of C. albicans. In addition, an in vitro application of 2.5% of the OEO-KMPs eradicated mature C. albicans biofilms while preserving Lactobacillus species. In in vivo, a single intravaginal application of OEO-KMPs induced a reduction in C. albicans growth, while maintaining Lactobacillus species. In conclusion, this therapeutic approach with OEO-KMPs is promising as a potential alternative or complementary therapy for VVC while preserving vaginal microflora.


  • Open Access

    Three-Dimensional Melted Electrowriting Drug Coating Fibers for the Prevention of Device-Associated Infections: A Pilot Study

    by Joana P. Martins, Elisabete T. da Silva, António A. Fernandes, Sofia Costa de Oliveira

    Medical device-related infections (DRIs), especially prevalent among critically ill patients, impose significant health and economic burdens and are mainly caused by bacteria. Severe infections often necessitate device removal when antibiotic therapy is inefficient, delaying recovery. To tackle this issue, PCL drug-eluting coated meshes were explored, and they were printed via melt electrowriting (MEW). These meshes were coated with gentamicin sulfate (GS) and tetracycline hydrochloride (TCH) and underwent FTIR analysis to confirm drug integration. Antimicrobial activity was assessed via agar diffusion assays and biofilm formation assays against bacterial strains: Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 43300, and Staphylococcus epidermidis ATCC 35984. FTIR analysis evidenced the presence of the drugs in the meshes. TCH displayed broad-spectrum antimicrobial activity against all strains, whereas GS was effective against all except S. aureus. These findings indicate the potential of cost-effective ultra-fine drug coating fibers for medical device applications, offering infection prevention during implantation. This preliminary study demonstrates the feasibility of producing drug-eluting fibers for DRI prevention through a non-toxic, fast, and cost-efficient technique, paving the way for enhanced patient care and reduced healthcare costs.